Herspiegel completed the acquisition of FIECON.

Herspiegel, a provider of pharmaceutical and biotech commercialization services, completed the acquisition of FIECON, a health economics and market access consultancy firm. Financial terms were not disclosed. This strategic integration expands Herspiegel's proven market access capabilities and enhances Herspiegel's global footprint. The integrated global access services will support patient access to life-saving and life-altering therapies through industry-leading expertise across the access value chain including strategy, health economic modeling, outcomes research, Health Technology Assessments (HTA), value communications, pricing and reimbursement, and Real-World Evidence (RWE).